Qiong Zhou

Professional Research Associate

University of Colorado Anschutz Medical Campus

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Qiong Zhou is a Professional Research Associate at the University of Colorado Anschutz Medical Campus, USA. Their research primarily focuses on cancer therapeutics, including the inhibition of CHD1L and the discovery of PARP1-HPF1 complex inhibitors. Recent publications explore innovative strategies for targeting cancer cell proliferation and addressing molecular subtypes of bladder cancer.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Johannes Rudolph

University of Colorado Boulder

UNITED STATES

View details

Laura Pike

Sr. Professional Research Assistant

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

THOMAS CECH

University of Colorado Boulder

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Qiong Zhou

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer

The validation of new CHD1L inhibitors as a therapeutic strategy for cancer

HTS discovery of PARP1-HPF1 complex inhibitors in cancer

Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer.

High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling.

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.

Advanced High-Content-Screening Applications of Clonogenicity in Cancer.

Collaborators (3)

Johannes Rudolph

Laura Pike

THOMAS CECH

Make your next move.